2023
DOI: 10.1039/d3md00423f
|View full text |Cite
|
Sign up to set email alerts
|

Naphthyl bearing 1,3,4-thiadiazoleacetamides targeting the parasitic folate pathway as anti-infectious agents: in silico, synthesis, and biological approach

Kavita Pal,
Sahil Lala,
Priyanka Agarwal
et al.

Abstract: Naphthyl bearing 1,3,4-thiadiazoleacetamides targeting the parasitic folate pathway as antimalarials and antileishmanial agents.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 51 publications
0
1
0
Order By: Relevance
“…To counter drug resistance, several researchers are continuously striving to develop diverse classes of heterocyclic molecules, including quinolines, 1 thieno [2,3- d ]pyrimidine, 2 dipeptide-sulfonamides, 3 spirooxindoles, 4 pyrimidine, 5 and molecular hybrids. 6–8 The heterocyclic motif pyrazine exhibits diverse pharmacological properties and has been explored to develop antimycobacterial, antibacterial, antifungal, antidiabetic, diuretic, anticancer, antiviral, hypnotic, and analgesic agents. Some of the pyrazine derivatives are now clinically recognized drugs all over the world.…”
Section: Introductionmentioning
confidence: 99%
“…To counter drug resistance, several researchers are continuously striving to develop diverse classes of heterocyclic molecules, including quinolines, 1 thieno [2,3- d ]pyrimidine, 2 dipeptide-sulfonamides, 3 spirooxindoles, 4 pyrimidine, 5 and molecular hybrids. 6–8 The heterocyclic motif pyrazine exhibits diverse pharmacological properties and has been explored to develop antimycobacterial, antibacterial, antifungal, antidiabetic, diuretic, anticancer, antiviral, hypnotic, and analgesic agents. Some of the pyrazine derivatives are now clinically recognized drugs all over the world.…”
Section: Introductionmentioning
confidence: 99%